FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 1851287 · Received October 4, 2010

Report

Report Number
2124215-2010-16455
Event Type
Injury
Date Received
October 4, 2010
Date of Event
July 1, 2010
Report Date
July 1, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. RESISTANCE AND PRESSURE TESTS WERE COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE AND INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT SHORTLY AFTER THE IMPLANT PROCEDURE; THIS RIGHT VENTRICULAR LEAD BECAME DISLODGED DUE TO THE REARRANGEMENT OF THE PATIENT INTO HIS BED AND THROUGH AN UNFAVORABLE MOVEMENT OF THE ARM. A REVISION PROCEDURE WAS PERFORMED; THE LEAD WAS REMOVED AND REPLACED WITH A LONGER LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4097

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention